Gufic Biosciences Limited has informed the Exchange about Transcript
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has informed the stock exchanges that the written transcript of its earnings conference call held on February 16, 2026 has been uploaded on the company's website. This is filed as a routine compliance disclosure under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). Investors can access the transcript through the link provided in the filing. The earnings call itself was previously intimated to the exchanges on February 16, 2026. No financial figures or forward-looking statements are included in this particular filing — it only confirms the availability of the transcript.
This is a standard regulatory disclosure with no direct impact on the stock price. Retail investors looking for management commentary on business outlook, margins, or strategy should review the full transcript available on Gufic's website.